Back to results
US 2026/0232833 A1Published application
Anti-her2 antibody-drug conjugate for treating breast cancer
AssigneesJiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai Shengdi Pharmaceutical Co., Ltd.
InventorQuanren WANG
Life of this patent
Estimating the term…
Abstract
Use of an anti-HER2 antibody-drug conjugate in the preparation of a drug for treating HER2 low-expression breast cancer. The structure of the antibody-drug conjugate is represented by formula (I).
Claims22
A method for treating breast cancer with low HER2 expression, comprising administering to a subject in need thereof an anti-HER2 antibody-drug conjugate, wherein the antibody-drug conjugate has a structure represented by formula (I):
- wherein:
- n is a decimal or integer from 3 to 8;
- Pc is an anti-HER2 antibody.
-14. (canceled)
(canceled)
Dependencies are inferred from the claim text.